Vision of APH Convention

Building on the strong legacy of EAPB, the African Pharma, Biotech and Health Supplies Convention (APH), will continue to be hosted in Rwanda and represents a strategic expansion of the platform’s original mandate. The 2026 edition positions APH as a continental forum engaging all African regions to strengthen manufacturing capabilities, human capital, innovation ecosystems, regulatory and policy frameworks, and access to capital across the pharmaceutical and biotech value chain. Through focused technical dialogue, partnership building, and actionable pathways for industrial growth, APH now serves as an African convergence platform addressing shared priorities in pharmaceutical, vaccine, medical device, and diagnostics manufacturing. By convening policymakers, regulators, manufacturers, scientists, investors, and development partners, APH supports Africa’s journey toward health security, industrial transformation, and innovation-led growth, catalyzing the partnerships and structural reforms needed to build a resilient, competitive, and regionally integrated pharmaceutical and biotech ecosystem.

Concept Note

Objectives

African Pharma, Biotech and Health Supplies Biotech convergence

A unified platform convening pharma and biotech stakeholders across Africa to drive regionally grounded and continent-wide impact.

Highlight Ongoing Key Initiatives on Capacity Development

Showcase and amplify transformative initiatives strengthening Africa’s health and biotech capacity.

Cross-stakeholder Ideation

Foster collaborative thinking to co-create scalable, high-impact solutions by providing a platform enabling interactions across all stakeholders.

Strategic Partnerships

Catalyse strategic partnerships that accelerate innovation, investment, and sustainable growth of regional manufacturing.

Learning & Networking Opportunities

Enable knowledge exchange and meaningful connections among diverse ecosystem actors.